Breaking News
November 27, 2024
Ravindra Warang
Simantini Singh Deo
Simantini Singh Deo
Simantini Singh Deo
NorthStar and PDRadiopharma team up to advance cancer diagnostics and treatments with innovative radiopharmaceuticals.
Simantini Singh Deo
Teva to sell its Teva-Takeda joint venture in Japan to JKI, focusing on its Pivot to Growth strategy and innovative medicines.
Simantini Singh Deo
ProBio appoints new leadership to accelerate biotech innovations: Allen Guo as CEO, Whitney Winters as SVP, and Michael Vreeland as U.S. Site Head.
Simantini Singh Deo
MaaT Pharma administers MaaT013 to the first U.S. patient with refractory aGvHD under FDA compassionate use, offering new hope.
Mrudula Kulkarni